Detalhe da pesquisa
1.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat
; 188(2): 477-487, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852121
2.
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma.
Med Oncol
; 22(3): 257-67, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16110137